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The functions of two conserved residues, Phe135 and Pro136,
located at the apex of the Cys loop of the nicotinic acetylcholine
receptor are investigated. Both residues were substituted with
natural and unnatural amino acids, focusing on the role of aro-
maticity at Phe135, backbone conformation at Pro136, side chain
polarity and volume, and the specific interaction between the
aromatic side chain and the proline. NMR spectroscopy studies
of model peptides containing proline and unnatural proline
analogues following aPhe showa consistent increase in the pop-
ulation of the cis conformer relative to peptides lacking the Phe.
In the receptor, a strong interaction between the Phe and Pro
residues is evident, as is a strong preference for aromaticity and
hydrophobicity at the Phe site. A similar influence of hydropho-
bicity is observed at the proline site. In addition, across a simple
homologous series of proline analogues, the results reveal a cor-
relation between receptor function and cis bias at the proline
backbone.This could suggest a significant role for the cis proline
conformer at this site in receptor function.
The Cys loop superfamily of neurotransmitter-gated ion
channels includes the nicotinic acetylcholine receptor
(nAChR),2 the 5-HT3 serotonin receptor, the GABAA and
GABAC receptors, and the glycine receptor (1, 2). Together,
these receptors mediate both excitatory and inhibitory fast
synaptic transmission throughout the central and peripheral
nervous systems. They are established targets for potential
treatments of Alzheimer disease, Parkinson disease, schizo-
phrenia, attention deficit hyperactivity disorder (ADHD),
addiction, and other neurological disorders.
The eponymous Cys loop, a disulfide-linked sequence Cys-
Xaa13-Cys, is located at the interface between the extracellular
and transmembrane domains of the receptor, andmany studies
have established that the Cys loop is essential for receptor func-
tion. Not part of the agonist binding site, the Cys loop probably
plays a key role in receptor gating, transmitting structural
changes initiated by agonist binding to the ion channel region
of the receptor (3–7).
The intervening residues of the Cys loop show considerable
conservation across the family (Fig. 1). Specifically, a com-
pletely conserved Phe-Promotif (followed by Phe orMet) lies at
the apex of the Cys loop. (These are residues 135 and 136 in the
1 subunit of the muscle-type nAChR, which is the system
studied here.) Proline residues are unique among the 20 natural
amino acids in several ways. Of particular interest here is the
much greater tendency of prolyl peptide bonds to exist in the cis
conformation (8–12). The presence of the Phe in the Phe-Pro
motif makes this possibility more enticing. It is well established
that an aromatic amino acid N-terminal of a proline enhances
the likelihood of a cis conformation, roughly doubling the con-
tribution of the cis peptide in the conformational equilibrium
(12). Indeed, previous studies of the analogous motif in the
5-HT3 receptor using conventional mutagenesis led to a postu-
lation that the Pro was in a cis conformation (13).
Currently available structural information related to Cys
loop receptors adds to the intrigue (Fig. 2). (Note that the ace-
tylcholine-binding protein, arguably the most valuable struc-
turalmodel for the extracellular domain, does not contain aCys
loop and does not contain the Phe-Pro sequence (14).) In the
medium resolution electron microscopic structure of the Tor-
pedo nAChR (Protein Data Bank code 2BG9), the proline of the
1 subunit is in the trans conformation, and there is clearly no
structural interaction at all between the side chains of Phe135
and Pro136 (15). In contrast, in the high resolution x-ray crystal
structure of themousemuscle nAChR1-subunit extracellular
domain complexed to-bungarotoxin (ProteinData Bank code
2QC1), the proline is in its cis form, and the Phe-Pro rings are
stacked (16). (The Torpedo and mouse muscle receptors show
very high sequence identity/similarity throughout their struc-
tures). Additionally, an NMR study of the isolated Cys loop of
the nAChR found a roughly 1:1 mixture of cis and trans con-
formers, a ratio that can be modulated by glycosylation (17).
In recent years, several pentameric prokaryotic channels that
are clearly related to the Cys loop receptors have been discov-
ered and crystallized. Although these bacterial channels lack
the cysteines of the Cys loop, they all contain a Phe/Tyr-Pro
motif, and x-ray crystal structures confirm that the loop is still
clearly in place. In a structure of the ELIC bacterial channel,
which is believed to be a closed state (Protein Data Bank code
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2VL0), the proline is in the trans conformation, and the Phe-
Pro side chains are stacked (18). Very recently, two structures of
the GLIC bacterial channel have appeared, and both are
thought to be an open state of the channel. Both structures
contain a completely stackedTyr-Promotif, but in one (Protein
Data Bank code 3EAM), the proline is cis (19), and in the other
(3EHZ) the proline is trans (20).
Together, the structural data strongly indicate that (i) in the
highly conserved Phe-Pro motif at the apex of the Cys loop of
Cys loop receptors, both cis and trans conformations around
the prolyl amide bond are viable, and (ii) an interaction between
the Phe and Pro side chains is possibly involved in the confor-
mational preference. Although it is true that the three-dimen-
sional fold of a protein may influence the cis preference of any
given residue, the intrinsic conformational bias of the residue
itself can still be expected to play an important role in deter-
mining structure and thus function of the protein (12).
The feasibility of both cis and trans conformations at Pro136
presents the tantalizing opportunity that cis-trans isomeriza-
tion of this conserved proline in the Cys loop, facilitated by the
adjacent Phe, might be involved in the receptor gating mecha-
nism. Such a cis-trans isomerization at a different proline has
been shown to be essential to channel gating in the 5-HT3
receptor (5).
In the present work, we have used a variety of tools to probe
the Phe-Promotif of themuscle-type nAChR, including unnat-
ural amino acid mutagenesis, electrophysiology, and NMR
spectroscopy of model peptides. We find evidence for a strong
interaction between the two residues and an important role for
the aromatic nature of the Phe. At both sites, side-chain hydro-
phobicity is favorable to the receptor function. In addition,
some preference for cis-biased residues at the Pro site is
observed, but the involvement of cis-trans isomerization or the
specific role of a cis conformer, if any, remains to be firmly
established.
EXPERIMENTAL PROCEDURES
Synthesis of dCA-Amino Acids—The preparations of amino
acids coupled to the dinucleotide (dCA) have been described
previously (21) with the exception of dCA-Dhp and dCA-Mor.
(S)-3-morpholinecarboxylic acid HCl was purchased from
Tyger Scientific Inc. (Ewing, NJ), and 3,4-dehydro-L-proline
(Dhp) was from Chem-Impex International Inc. (Wood Dale,
IL). The amino groups were protected as the O-nitroveratrylo-
xycarbonyl (NVOC) group. NVOC-Cl was purchased from
Aldrich. (NVOC)-3,4-Dehydroproline cyanomethyl ester and
(NVOC)-morpholine cyanomethyl ester were prepared
according to the representative protocol reported in Ref. 22.
Products were characterized by NMR spectroscopy. The NMR
spectra, both 1H and 13C, are complicated because each com-
pound shows two distinct conformations in the solution.
(NVOC)-3,4-Dehydroproline cyanomethyl ester. 1HNMR (500
MHz, CDCl3) 3.95–4.03 (m, 6H), 4.34–4.43 (m, 2H), 4.69–
4.87 (m, 2H), 5.20–5.21 (m, 2H), 5.43–5.67 (m, 2H), 5.76–5.83
(m, 1H), 7.01 (s, 1H), 7.71 (m, 1H). 13CNMR (125MHz, CDCl3)
49.20, 49.23, 53.57, 54.20, 56.54, 56.57, 56.87, 64.66, 65.08,
65.92, 66.28, 108.34, 108.37, 110.07, 111.25, 113.96, 113.98,
123.46, 123.71, 127.44, 127.85, 130.37, 130.49, 139.88, 139.92,
148.32, 148.43, 153.39, 153.76, 153.81, 153.96, 168.41, 168.83.
High resolution MS analysis (FAB) calcd for C17H18N3O8
m/z  392.1094, found 392.1109. (NVOC)-Morpholine cya-
nomethyl ester. 1H NMR (500 MHz, CDCl3) 3.24–3.48 (m,
1H), 3.51 (dt, 1H), 3.69–3.75 (m, 1H), 3.83–3.95 (m, 2H), 3.94–
3.95 (m, 3H), 3.99–4.02 (m, 3H), 4.33–4.41 (m, 1H), 4.63–4.85
(m, 3H), 5.41 (dd, 1H), 5.69 (dd, 1H), 6.88–6.97 (m, 1H), 7.66–
7.70 (m, 1H). 13CNMR (125MHz, CDCl3) 41.22, 41.73, 49.39,
49.45, 54.53, 55.05, 56.53, 56.60, 56.81, 64.91, 65.31, 66.29,
66.73, 66.99, 67.34, 108.32, 108.36, 109.91, 111.13, 113.84,
113.89, 126.93, 127.66, 139.78, 140.11, 148.32, 148.53, 153.66,
153.81, 155.14, 156.04, 168.69, 168.89. High resolution MS
analysis (FAB) calcd for C17H20N3O9 m/z 410.1199, found
410.1180.
Dhp and Mor cyanomethyl esters were coupled to dCA fol-
lowing the protocol in Ref. 22. dCA-Dhp. ES-MS calcd for
C34H40N10O20P2m/z 970.2; found (MH)m/z 969.0, (M
FIGURE 1. Sequence alignment of the Cys loop from various subunits of
the Cys loop superfamily.
FIGURE2. Imagesof thePhe/Tyr-Pro-Pheunit fromfivedifferent relevant
structures.
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Na  2H) m/z 991.1, and (M  Na  H) m/z 992.0. dCA-
Mor. ES-MS calcd for C34H42N10O21P2m/z 988.2; found (M
H)m/z 987.0, (M Na 2H)m/z 1009.0, and (M Na
H)m/z 1010.0.
Molecular Biology—Subunits of embryonic mouse muscle
nAChR were in pAMV vectors. The  subunit contains the
hemagglutinin epitope tag in the M3-M4 loop. There is no sig-
nificant shift in EC50 caused by the insertion of the hemagglu-
tinin epitope tag at this location. Site-directedmutagenesis was
performed using the Stratagene QuikChange protocol. For sin-
gle unnatural amino acid incorporation, the site of interest was
mutated to an amber stop codon. For double unnatural acid
incorporation, the 135 site was mutated to the opal stop codon,
and the 136 site wasmutated to the amber stop codon. Circular
cDNA was linearized with NotI or KpnI. After purification
(Qiagen), linearized DNA was used as a template for run-off in
vitro transcription using the T7 mMessage mMachine kit
(Ambion). The resulting mRNA was purified (RNAeasy mini-
kit, Qiagen) and quantified by UV-visible spectroscopy.
THG73 (23) and TQOpS (24, 25) were used as amber sup-
pressor tRNA and opal suppressor tRNA, respectively. Conju-
gated dCA-amino acid was ligated to 74-nucleotide tRNA as
previously reported (21). Crude tRNA-amino acid product was
used without desalting, and the product was confirmed by
matrix-assisted laser desorption ionization time-of-flight MS
on a 3-hydroxypicolinic acid matrix. Deprotection of the
NVOC group on tRNA-amino acid was carried out by 5-min
photolysis immediately prior to injection.
Microinjection—Stage V-VI Xenopus laevis oocytes were
employed. For wild-type receptor and receptors containing
conventional mutations, quantified mRNAs of all subunits
were mixed in a ratio of /// 2:1:1:1 by mass. If an unnat-
ural amino acid was to be incorporated into the  subunit, the
mRNA stoichiometry was ///  10:1:1:1 by mass. Total
amount of injected mRNA was 0.5–5 ng/cell for the wild type,
5–50 ng/cell for conventional mutations, and 25–125 ng/cell
for suppressionmutations.MoremRNAwas used in the double
mutation experiments and with some mutations that gave
abnormally low expression level. Equal volumes of the mRNA
mixture and unprotected tRNA-amino acid were mixed prior
to injection. Approximately 15 ng of tRNA/cell was used in the
single suppression experiments, and 50 ng was used in the dou-
ble suppression experiments. Each oocyte was injected with 50
nl of RNA solution, and cells were incubated for 18–72 h at
18 °C in culture medium (ND96 with 5% horse serum). In the
case of low expressingmutant receptors, a second injectionwas
required. As a negative control for all suppression experiments,
76-nucleotide tRNA (dCA ligated to 74-nucleotide tRNA) was
co-injected with mRNA in the same manner as fully charged
tRNA.
Electrophysiology—Acetylcholine chloride and succinylcho-
line dihydrate were purchased fromSigma. Drug dilutionswere
prepared from 1 M stock solutions in the calcium-free ND96
buffer.
Ion channel function in oocytes was assayed by current
recording in two-electrode voltage clamp mode using the
OpusXpress 6000A (Axon Instruments). For dose-response
experiments, 1ml of each drug solutionwas applied to the cells,
and between 12 and 16 concentrations of drug were used.
Oocytes were clamped at 60 mV. Cells were perfused in cal-
cium-free ND96 solution at flow rates of 1 ml/min before ago-
nist application, 4 ml/min during agonist application, and 3
ml/min during wash. Drug application was 15 s in duration.
Data were sampled at 125 Hz and filtered at 50 Hz.
Data Analysis—All dose-response data were obtained from
at least five cells and at least two batches of oocytes. Data were
normalized (Imax  1) and averaged. EC50 and Hill coefficient
(nH) were determined by fitting averaged, normalized dose-re-
sponse relations to the Hill equation. Dose responses of indi-
vidual oocytes were also examined and used to determine out-
liers. Individual dose-response data with nH 2 or nH 1 were
discarded.
The coupling parameter () between any two mutations at
residues 135 and 136 was calculated from Equation 1,
  EC50double mutation	 EC50wild type		/
EC50(135 mutation	 EC50136 mutation	) (Eq. 1)
Side chain logP values were obtained using theChemDrawpro-
gram (CambridgeSoft Corp.).
Synthesis of Fmoc-protected Amino Acid—Fmoc-Cl was pur-
chased from Fluka. (S)-3-Morpholinecarboxylic acid HCl was
purchased from Tyger Scientific Inc. (Ewing, NJ), (2S,3S)-3-
methylpyrrolidine-2-carboxylic acid (3-Me-Pro) was from
Acros Organics USA (Morris Plains, NJ), -methyl-L-proline
(2-Me-Pro) was from Fluka, and Dhp was from Chem-Impex
International Inc. (Wood Dale, IL). The amino acids were cou-
pled to the Fmoc protecting group using the following protocol.
L-Amino acid (0.06 mmol) was dissolved in 10% Na2CO3 in
water (2 ml), resulting in a solution with pH 
9. To this solu-
tion was added Fmoc-Cl (1.5 eq) in dioxane (2 ml) at room
temperature. Diisopropylethylaminewas added dropwisewhile
the reaction was stirred. Typically, the reaction was complete
within 6 h. The reaction mixture was diluted by the addition of
brine (20 ml). This was extracted with ether (5 ml) five times.
The aqueous layer was acidified with 6 N HCl to pH 
1 (solu-
tion became cloudy) and extractedwith ether (5ml) three times
or until the organic layer was clear. The combined organic lay-
ers were dried over Na2SO4, and the solvent was removed
under reduced pressure. Crude product was dried under
vacuum overnight and was used in the next step (solid-phase
peptide synthesis) without further purification. N-Fmoc-2-
methyl-proline. 1H NMR (500 MHz, CDCl3) 1.26–1.62 (m,
3H), 1.75–1.98, (m, 3H), 2.15–2.42 (m, 1H), 3.51–3.63 (m, 2H),
4.13–4.56 (m, 3H), 7.27–7.41 (m, 4H), 7.55–7.61 (m, 2H), 7.70–
7.77 (m, 2H). 13CNMR (125MHz, CDCl3) 22.31, 22.72, 22.83,
23.42, 39.23, 41.11, 47.48, 47.58, 48.28, 48.91, 65.00, 66.28,
67.25, 67.65, 120.12, 120.20, 124.92, 124.95, 125.30,
125.35,127.27, 127.29, 127.30, 127.74, 127.78, 127.93, 141.54,
141.56, 141.60, 141.62, 144.05, 144.17, 144.21, 144.43, 154.86,
155.35, 178.42, 179.54. High resolution MS analysis (FAB)
calcd for C21H22NO4 m/z  352.1549, found 352.1534.
N-Fmoc-3-methyl-proline. 1HNMR (500MHz, CDCl3) 1.17–
1.28 (m, 3H), 1.49–1.63 (m, 1H), 2.01–2.15 (m, 1H), 2.40–2.49
(m, 1H), 3.50–3.68 (m, 2H), 3.85–3.97 (m, 1H), 4.12–4.28 (m,
1H), 4.33–4.46 (m, 2H), 7.27–7.41 (m, 4H), 7.53–7.62 (m, 2H),
Phe-ProMotif in Cys Loop Receptors
8978 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 12•MARCH 19, 2010
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y, on M
arch 26, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
http://www.jbc.org/content/suppl/2010/01/12/M109.060939.DC1.html
Supplemental Material can be found at:
7.69–7.77 (m, 2H). 13C NMR (125 MHz, CDCl3) 18.65, 18.91,
31.58, 32.50, 38.24, 39.70, 45.92, 46.29, 47.27, 47.30, 65.59,
66.07, 67.72, 67.77, 119.94, 119.97, 120.04, 125.05, 125.11,
125.16, 125.24, 127.10, 127.13, 127.15, 127.68, 127.78, 127.79,
141.27, 141.34, 141.36, 141.39, 143.80, 143.84, 144.07, 144.12,
154.75, 155.46, 176.79, 177.69. ESIMS on an LCQ ion trapmass
spectrometer (positive ion mode) calcd for C21H21NO4 m/z
351.1, found 351.9. N-Fmoc-morpholine. 1H NMR (500 MHz,
CDCl3) 3.04–3.92 (m, 6H), 4.20–4.68 (m, 5H), 7.27–7.34 (m,
2H), 7.36–7.42 (m, 2H), 7.48–7.60 (m, 2H), 7.71–7.77 (m, 2H).
13C NMR (125 MHz, CDCl3) 41.16, 41.73, 47.27, 54.45, 54.84,
66.37, 66.75, 67.32, 67.72, 67.77, 68.12, 120.11, 120.14, 124.79,
124.89, 125.13, 127.19, 127.25, 127.27, 127.86, 127.90, 141.37,
141.42, 141.45, 141.48, 143.78, 143.82, 143.94, 155.91, 156.58,
174.83, 175.02. ESI MS on an LCQ ion trap mass spectrometer
(positive ion mode) calcd for C20H19NO5Na m/z  376.1,
found 376.3.
Solid-phase Peptide Synthesis—All peptides were synthe-
sized by solid-phase methods from Fmoc-protected amino
acids using HBTU (Fluka) as a coupling reagent. Fmoc-L-pro-
line was purchased from Sigma, Fmoc-L-pipercolic acid was
from Peptech Corp. (Burlington, MA), Fmoc-L-azetidine-2-
carboxylic acid was from Fluka, Fmoc-cis-2-fluoro-L-proline
was from AnaSpec Inc. (San Jose, CA), N-Fmoc-glycine was
from Aldrich, and Fmoc-L-phenylalanine was from Sigma. All
chemicals were used as purchased without purification.
PAL resin (Sigma; estimated 0.4–0.8 mmol/g loading, 1%
cross-linked with divinylbenzene, 100–200 mesh) was used to
afford C-terminal primary amides. For conventional amino
acids, couplings were performed with 3 eq of Fmoc amino acid,
3 eq ofHBTU, and 6 eq of diisopropylethylamine. For unnatural
amino acids, couplings were performed with 2 eq of Fmoc
amino acid, 2 eq of HBTU, and 4 eq of diisopropylethylamine.
The reaction time for each coupling step was 1–2 h. A Kaiser
test was performed to monitor the progress of the reaction.
After each coupling step, unreacted free amine was acetylated
(5% acetic anhydride and 5% pyridine and 90%DMF) for 8min,
followed by deprotection of Fmoc-protected amine groups
(20% piperidine/DMF, 15 min). In the last step, after Fmoc
deprotection, the peptides were acetylated at the N termini on
the resin using a solution of 5% pyridine, 5% acetic anhydride,
and 90% DMF. Peptides were cleaved from the resin by treat-
ment with trifluoroacetic acid and water (95:5) for 2 h. After
filtration to collect the filtrate, solvents were removed as much
as possible under reduced pressure. Following the addition of
5% acetic acid solution, this solutionwas lyophilized to dryness.
The peptides were purified by preparative scale reversed phase
high pressure liquid chromatography with gradient elution
using an A-B gradient (buffer A, 0.05% trifluoroacetic acid in
water; buffer B, 20% water and 0.05% trifluoroacetic acid in
acetonitrile) and a flow rate of 15 ml/min. Peptide identity was
characterized by ESIMSon anLCQ ion trapmass spectrometer
(positive ion mode). GFProG (M  Na) expected 440.2, ob-
served 440.3. GF(2-Me-Pro)G (M  Na) expected 454.2,
observed 454.3. GF(3-Me-Pro)G (M  Na) expected 454.2,
observed 454.4. GFflpG (M  Na) expected 458.2, observed
458.4. GFAzeG (M  Na) expected 426.2, observed 426.2.
GFPipG (M Na) expected 454.2, observed 454.3. GFMorG
(M Na) expected 456.2, observed 456.2. Note that the syn-
thesis of Gly-Phe-Dhp-Gly peptide did not give the desired
product in the first trial, and no further attempt has been made
to obtain the product.
NMR Spectroscopy of Model Peptides—The peptide samples
were dissolved in 5 mM phosphate buffer with 25 mM NaCl in
90% H2O, 10% D2O at pH 5. Samples for NMR experiments
were between 2 and 5 mM. NMR spectra were acquired on a
Varian 600-MHz spectrometer, and the temperature was set to
298 K. The water signal was suppressed by presaturation.
Sequential assignments were achieved using gradient-selected
correlated spectroscopy (gCOSY) and total correlation spec-
troscopy (TOCSY) experiments. Spectra were all internally ref-
erenced to 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium
salt (
200 M final concentration) at 0.0 ppm. The fraction of
cis conformer was determined by integrating well resolved
peaks in the one-dimensional 1H NMR spectra after base-line
correction. NMR data were processed using the MestReNova
software version 5.1.0 (Mestrelab Research S.L.).
RESULTS
Mutational Studies at Pro136—A previous study of the mus-
cle-type nAChR inHEK293 cells showed that P136Gmutations
in the  and  subunits prevented receptor assembly, whereas
analogous mutations in the  or  subunits prevented traffick-
ing of receptors to the cell surface (26). Similarly, in previous
studies of the analogous proline in the homopentameric 5-HT3
receptor, the P136A mutant revealed no surface expression in
HEK293 cells (13). In the more permissive Xenopus oocyte
expression system, the muscle-type nAChR containing the
P136Amutation produces10% of the current levels seen for
wild type. Surprisingly, this mutant receptor has an ACh EC50
value similar to that of the wild type. As discussed below, this
result can be interpreted in several different ways; we therefore
anticipated that the more subtle mutations enabled by unnatu-
ral amino acid mutagenesis would provide a more revealing
analysis of the role of this residue.
Several unnatural analogues of proline (Fig. 3) (5) were incor-
porated into the receptor using the in vivo nonsense suppres-
sion method. These unnatural proline analogues have varying
ring size, side chain substitution, and intrinsic preferences for
the cis conformerwhen probed inmodel systems (Table 1). The
wild-type rescue experiment (i.e. incorporating Pro by non-
sense suppression) displays the full phenotype of the wild-type
receptor, including ACh EC50 value, Hill coefficient, and cur-
rent traces. This indicates that the nonsense suppressionmeth-
odology is viable at the 136 site. Interestingly, Pro analogues at
position 136 are generally gain-of-function (lower EC50), the
sole exception being 2-Me-Pro, which gives essentially wild-
type behavior. Similar to the Ala mutation mentioned above,
the current levels from experiments involving 2-Me-Pro are
10% of those seen in comparable experiments with other
mutations. Despite the relative subtlety of the mutations, the
gain-of-function effects can be substantial, as seen with Pip and
3-Me-Pro, which show 13- and 22-fold decreases in EC50,
respectively, relative to wild type.
Correlation between the cis-trans energy gap and the energy
of channel activation could be expected if the receptor gating
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mechanism involves cis-trans isomerization of Pro136. How-
ever, no simple correlation is found (Table 1). For example,
although both Pip and Aze show a stronger inherent cis prefer-
ence than Pro and a lower EC50, 3-Me-Pro shows a conforma-
tional bias very similar to that of Pro but a greatly diminished
EC50. Before analyzing these results in greater detail, however,
we must consider the role of Phe135.
Mutational Studies at Phe135—Previous single channel stud-
ies have shown that the F135A mutation in the nAChR alters
the gating mechanism, leading to two uncoupled open states
that produce independent gating reactions from the diliganded
closed state (27). In our studies of the nAChR,we found that the
F135Amutation nearly obliterates receptor function; only very
weak ACh-induced currents are observed despite normal sur-
face expression levels (supplemental Fig. 1).
Seeking a more insightful analysis of the role of this residue,
we probed the Phe135 site with an extensive series of Phe ana-
logues. Again, the wild type rescue experiment displays the full
characteristics of the wild-type receptor. The Phe135 site is sen-
sitive to even very subtle mutations, as shown in Table 2. Sim-
ilar to what is observed with Pro136, Phe analogues consistently
produce gain-of-function mutants.
ACh sensitivity increases with the
volume and number of hydrophobic
substituents on the aromatic ring.
For example, Me-Phe has a lower
EC50 than F-Phe, andMe2-Phe has a
lower EC50 than Me-Phe. Surpris-
ingly, cyclohexylalanine (Cha),
which is similar to Phe in size and
shape but is not aromatic (28), pro-
duces functional receptors with a
small perturbation; EC50 is near the
wild-type value. Given that the
F135Cha mutant receptor is func-
tional, aromaticity at position 135 is
not an absolute requirement for the
receptor to function.
To further explore the possible
role of Phe135 in receptor gating,
wild-type and mutant receptors
were probed with the partial agonist
succinylcholine (SuCh). Compared with ACh, SuCh produces
only 14%of themaximal current under saturating drug concen-
trations in the wild-type receptor (Table 2). This indicates that
upon receptor activation by SuCh, the channel open-closed
equilibrium is shifted toward the open state, but to a much
lesser extent relative to ACh activation. If a mutation produces
a gain-of-function effect as a result of enhanced receptor gating,
one could expect the mutation to improve the efficacy of a par-
tial agonist like SuCh.
The EC50 trend of SuCh (Table 2) parallels that of ACh,
implying that the mutants respond to both drugs in the same
way. As anticipated, all of the Phe analogues that show a low-
ered EC50 do increase the relative efficacy of SuCh with respect
to ACh. This suggests that mutations at position 135 primarily
affect receptor gating. Note that the non-aromatic analogue
Cha shows essentially wild-type EC50 for both ACh and SuCh
and that this mutation has no strong effect on the relative
efficacy.
Interaction between Phe135 and Pro136—There is consider-
able evidence supporting a specific interaction in a Phe-Pro
sequence that stabilizes the cis form of the Pro. This could pos-
sibly involve a polar- interaction in which polarized C–H
bonds (C–H) on the proline interact favorably with the
negative electrostatic potential on the face of the Phe side chain
stacked on the Pro (9, 11). We investigated the possibility of a
Phe-Pro interaction in this system by testing double mutant
receptors in which Phe135 was substituted with the non-aro-
matic Cha and Pro136 was substituted with either Pip or 3-Me-
Pro, the twomutations that cause the largest EC50 shifts. These
experiments required consecutive incorporation of two differ-
ent unnatural amino acids, an unprecedented experiment for
receptors expressed in a living cell that was made possible by
recent advances in tRNA design (24, 25). The resulting current
signals (1–4 A) were quite sufficient for quantitative analysis.
The F135Cha mutation substantially diminishes the large
effects of the mutations at Pro136. As shown in Fig. 4, the 13-
and 22-fold drops in EC50 for Pip and 3-Me-Pro, respectively,
FIGURE 3. Structures of unnatural amino acids used in this study.
TABLE 1
EC50 and Hill constant values of mutant receptors containing
unnatural amino acid at 136
Pro136 Reportedpercentage cisa ACh EC50
EC50(mut)/EC50(wild type)
Hill
constant n
% M
Pro 5 23 0.2 1 1.5 0.02 35
Prob 5 22 0.2 1 1.6 0.03 8
Pip 12 1.8 0.1 0.1 1.7 0.08 7
Aze 18 5.8 0.2 0.3 1.7 0.07 10
Flp 
5 12 0.2 0.5 1.5 0.04 6
Flp 
5 10 0.2 0.5 1.7 0.04 7
3-Me-Pro 
5 1.0 0.02 0.04 1.7 0.04 7
2-Me-Pro 0 25 0.7 1 1.6 0.06 10
Dhp NRc 18 0.3 0.8 1.6 0.03 10
Mor NRc 8.7 0.4 0.4 1.7 0.05 9
a Refs. 5 and 8.
b Data obtained by suppression mutation.
cNR, percentage cis values for these residues have not been previously reported in
the literature.
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seen in a wild-type Phe background fall to 
2.5-fold in the
presence of F135Cha. A standard evaluation of double mutants
employs a mutant cycle analysis, which has been used success-
fully with EC50 values for Cys loop receptors in several
instances (29–32). For the interaction of F135Cha with
P136Pip and P136(3-Me-Pro), we find coupling parameters ()
of 5 and 10, respectively, which correspond to coupling energies
(RTln()) of 1.0 and 1.3 kcal/mol, respectively. These energies
are significant for such subtle mutations and are indicative of a
strong interaction between these two residues.
Having established a strong interaction between Phe135 and
Pro136, we considered whether the intrinsic cis-trans equilib-
rium reported for proline and the proline analogues would be
altered because of the preceding Phe. This would indicate that
the percentage cis values used previously (5) and reported in
Table 1 may not be appropriate for the present system because
no aromatic amino acid was involved. As such, we set out to
determine percentage cis values that are more appropriate to
the Phe-Pro motif.
Determination of Inherent cis Preferences of Model Peptides
Containing Proline Analogues Preceded by Phe—In order to
determine whether the data in Table 1 reflect the innate cis
preference of residue Pro136, it is necessary to measure the cis-
trans energy gap (G(c-t)) for each unnatural amino acid sub-
stituted at this site, taking into account the aromatic-proline
interaction. In fact, G(c-t) for the Gly-Phe-Pro-Gly and Gly-
Phe-Pip-Gly peptides have been reported (33). Using a similar
solution NMR technique, it should be possible to determine
G(c-t) values for our series of unnatural analogues of proline
following a Phe residue in model peptides.
Model peptides Gly-Phe-XPro-Gly, where XPro represents
Pro, Pip, Aze, flp, Mor, 3-Me-Pro, and 2-Me-Pro, were synthe-
sized via standard solid-phase peptide synthesis methods.
These peptides were then subjected to solution NMR experi-
ments similar to those in Ref. 33. Protons were assigned by
two-dimensional gCOSY and/or TOCSY experiments. The
proportion of each of the two conformers in solution was mea-
sured by integration of a corresponding, well resolved peak
after base-line correction. (Representative sample spectra are
shown in supplemental Fig. 2). Conformational assignments
were based on known chemical shifts of the Gly-Phe-Pip-Gly
peptide reported in Ref. 33.
The results from the solution NMR experiments (Table 3)
show that the cis preferences are indeed higher than the
reported values in model peptides lacking the aromatic residue
(Table 1). Note that for the Gly-Phe-(2-Me-Pro)-Gly peptide,
the cis form was not observed. The model peptide containing
Mor has a very high cis propensity; nearly 50% of the peptide is
in the cis form.Moreover, one of the protons attached to the C
of the Mor ring displays a large upfield shift in the cis peptide
compared with that of the trans peptide (supplemental Table
1), as has also been reported with the structurally similar Pip
(33). In the Pip-containing peptide, the chemical shifts of C
protons are 1.72 and 2.15 ppm in the trans conformation and
0.35 and 1.90 ppm in the cis conformation. Likewise, for the
Mor-containing peptide, the chemical shifts change from
FIGURE4.AChEC50 results fromsingle anddoublemutationexperiments
at residues 135 and 136 in comparison with the wild-type value. For
F135Cha/P136Pip, EC50 6.5 0.2M, Hill constant 1.7 0.07, and n 9.
For F135Cha/P135(3-Me-Pro), EC50 6.9 0.2M, Hill constant 1.5 0.06,
and n 12.
TABLE 3
G(c-t) calculated from the percentage of cis results of solution
NMR experiments for each amino acid and theG(EC50) calculated
from electrophysiology results of mutant receptors containing the
corresponding amino acid at 136
G(c-t) RTln(% cis(Pro analogue)/% cis(Pro)). G(EC50)RTln(EC50(Pro
analogue)/EC50(Pro)).
XPro Percentage cis G(c-t) G(EC50)
% kcal/mol kcal/mol
Pro 17 0 0
Pip 39 0.65 1.5
Aze 30 0.42 0.81
Flp 32 0.49 0.38
3-Me-Pro 12 0.24 1.8
2-Me-Pro 0 0.056
Mor 48 0.87 0.57
TABLE 2
EC50 and Hill constant values of mutant receptors containing unnatural amino acid at 135
Phe135 ACh SuCh EfficacyaEC50 Hill constant n EC50 Hill constant n
M M
Phe 23 0.2 1.5 0.02 35 59 1 1.3 0.03 13 0.14 0.01
Pheb 23 0.4 1.5 0.03 8 NAc NA NA NA
F-Phe 2.6 0.03 1.6 0.02 7 32 0.8 1.4 0.04 9 0.54 0.02
F3-Phe 1.0 0.02 1.5 0.05 15 8.1 0.2 1.6 0.05 8 0.86 0.02
Me-Phe 1.0 0.02 1.6 0.04 12 11 0.2 1.5 0.04 11 0.82 0.02
Me2-Phe 0.22 0.01 1.6 0.07 9 1.6 0.06 1.5 0.07 7 0.93 0.04
Cha 16 0.2 1.6 0.02 15 60 1 1.6 0.03 9 0.10 0.01
a Determined by the average of Imax(SuCh)/Imax(ACh).
b Data obtained by suppression mutation.
cNA, data not available.
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3.74 and 4.37 ppm in the trans conformation to 2.10 and 3.74
ppm in the cis conformation. Most importantly, the Phe res-
idue can alter the trends in cis-trans preferences, as shown
for the simple homologous series Aze, Pro, Pip (Table 1 com-
pared with Table 3).
DISCUSSION
Cys loop neurotransmitter-gated ion channels are remarka-
ble molecular machines. In response to the binding of a small
molecule ligand, these large proteins undergo a global confor-
mational change, opening a selective ion channel and thereby
converting a chemical event (i.e. ligand binding) to an electrical
signal. The precise mechanism of this process is a central issue
in molecular neurobiology. Recently, chemical scale studies
have provided valuable insights into the structure and function
of these receptors, yet significant challenges still remain.
Herewehave evaluated the highly conserved and structurally
intriguing Phe135-Pro136 motif of the prototypic Cys loop
receptor, the nAChR. Proline is well appreciated to display
novel conformational behaviors compared with all other natu-
ral amino acids. Additionally, it has been proposed that prolines
might play a key role in the conformational changes that are
essential to the function ofmany types of receptors (34). Several
lines of evidence establish that local amino acids flanking pro-
line can influence proline conformational preferences (9, 11, 12,
35). In particular, an aromatic residue preceding the proline is
found to enhance the fraction of the cis isomer for peptides in
solution (12). As shown in Fig. 2, Pro136 can exist in both cis and
trans conformations, and the two crystal structures with a cis
peptide bond (2QC1 and 3EAM) show stacking of the Phe-Pro
side chains. Given the complete conservation of the Phe-Pro
motif and the available structural data, it seemed reasonable to
speculate that the cis conformer of Pro136 could be involved in
receptor function.
Our primary measure of receptor function is EC50, the effec-
tive concentration of agonist required to achieve half-maximal
response. Agonist binding to a receptor induces step-by-step
conformational changes that lead to opening of the ion channel;
therefore, EC50 is a value that reflects the composite effect
of the agonist binding affinity and the sequential gating events.
The Phe-Pro motif is remote from the agonist binding site, and
the Cys loop is firmly established to play an essential role in
gating (36). In addition, we find that a number of mutations at
residue 135 greatly increase the efficacy of the partial agonist
SuCh, supporting the notion that this residue participates in the
gating mechanism. As such, we interpret changes in EC50 to
reflect primarily, if not exclusively, changes in receptor gating.
The involvement of the Phe-Pro motif in gating is further
supported by a previous single channel study on the F135A
mutation, which indicated that the gating mechanism is modi-
fied as a result of this mutation (27). The new mechanism
appears to be much less efficient at coupling agonist binding to
channel opening, consistent with our macroscopic observa-
tions of greatly reduced current for this mutant.
Conventional mutations at Pro136 also have strong effects on
the receptor. When expressed in HEK293 cells, both Gly
mutants in the nAChR subunits and an Ala mutant in the
related 5-HT3 receptor (13) gave receptors that were substan-
tially impaired in the ability to assemble and/or traffic to the
surface. In the Xenopus oocyte system, we find that the P136A
mutant gave 10% of the current levels seen from wild type,
again suggesting a disruption of assembly and/or trafficking or a
disruption of gating.
Similarly, in an earlier study of Pro308 in the M2-M3 loop of
the 5-HT3 receptor, in which a compelling correlation between
cis propensity of incorporated proline analogues and receptor
function was demonstrated, structural disruption by conven-
tional mutagenesis produced ambiguous results (5). In that
study, Ala, Cys, Gly, Lys, Val, and Gln conventional mutants
gave nonfunctional receptors. More recently, studies of an
orthologous 5-HT3 receptor showed that His and Trp mutants
did give functional receptors (37).Wenote that aromatic amino
acids, such as His and Trp, aremore than twice as likely to be in
a cis conformation as other non-proline natural amino acids
(38). Again, the implications of the conventional mutagenesis
results are open to debate.
Using conventional mutagenesis to probe the role of the cis
conformation of a highly conserved proline is, in our view,
unlikely to produce compelling results. Such studies frequently
assume that simply seeing a functional receptor with a non-
proline natural amino acid incorporated rules out a role for the
cis conformer. However, previous studies have demonstrated
that in some cases, when a cis proline is mutated to an alanine,
the main-chain cis bond is preserved, presumably because the
three-dimensional structure favors the cis conformation (11).
In such cases, the Pro toAlamutation often reduces the stability
of the protein, which could manifest as lower expression levels,
as we see with the P136A mutant. In addition, as with Pro, the
presence of an aromatic amino acid (such as Phe)N-terminal to
an aliphatic residue (such asAla) doubles the probability of a cis
conformation (38). Alternatively, replacement of a proline with
another natural amino acid could produce functional receptors
via a different gating path that has become more energetically
accessible, parallel to what is seen with the F135A mutation
(27).
When studying such a structurally distinctive motif as Phe-
Pro, the benefits of unnatural amino acid mutagenesis are
amplified. The subtle perturbations allow one to maintain the
essential motif while probing its intrinsic features. We have
used unnatural amino acids to probe several aspects of the Phe-
Pro motif, including the importance of Phe aromaticity, the
roles of side chain hydrophobicity and volume, and the possi-
bility of cis-trans isomerization at the proline backbone.
Several intriguing observations emerge from the unnatural
amino acid mutagenesis studies. Considering Pro136, subtle
mutations produce noticeable changes in EC50. For example,
simply adding a methyl group (3-Me-Pro) can lower EC50
22-fold, and adding a single CH2 group to the ring (Pip) can
lower EC50 13-fold. Mutations are generally gain-of-function;
EC50 decreases. The only residue that is not gain-of-function
but instead gives nearly wild-type EC50 is 2-Me-Pro. Similar to
Ala, 2-Me-Pro also produces much smaller whole cell currents.
As with the proline, subtle mutations of Phe135 can produce
substantial changes in EC50; a 100-fold shift arises from just the
addition of two methyl groups fairly remote from the protein
backbone (Me2-Phe). Paralleling the proline results, all of the
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unnatural amino acid mutants are gain-of-function. Moreover,
an interesting trend is evident; Fig. 5 shows a plot of log(EC50)
for the receptor versus the side chain logP, a measure of its
hydrophobicity. Although the cyclohexyl compound (Cha) is
clearly an outlier, a significant correlation is seen among the
aromatic side chains. These results indicate that hydrophobic-
ity is an important determinant at position 135, with an
increase in hydrophobicity making the channel easier to open.
This is consistent with a molecular dynamics simulation of the
7 nAChR that places Phe135 in a hydrophobic pocket in an
open state (39). In addition, the logP analysis (Fig. 5) highlights
the role of aromaticity at residue 135 because Cha has essen-
tially the same hydrophobicity as both Me-Phe and F3-Phe but
a much higher EC50. As such, the F135Cha mutant, having
beingmore hydrophobic than the wild-type Phe but lacking the
aromaticity, appears to have a nearlywild-typeAChEC50. From
these data, we conclude that both hydrophobicity and aroma-
ticity at position 135 are important in receptor function.
The results of our double mutant studies have confirmed an
important interaction between residues 135 and 136; the large
effects caused by mutation at Pro136 are attenuated when
Phe135 is simultaneouslymutated to the non-aromaticCha (Fig.
4). Mutant cycle analysis shows significant coupling energies
between residues 135 and 136.
We noted above the intriguing possibility that cis-trans
isomerization at Pro136 is involved in receptor gating. In the
present work, we did not see a simple correlation between EC50
and previously reported innate percentage cis values of the Pro
analogues. However, there is ample precedent showing a devi-
ation of percentage cis from the innate value when the preced-
ing residue is aromatic (12). To probe the impact of the Phe
residue on the present system, we used NMR spectroscopy to
evaluate the cis-trans preference in the model peptides Gly-
Phe-XPro-Gly, where XPro represents Pro, Pip, Aze, flp, Mor,
3-Me-Pro, and 2-Me-Pro. Because the cis form of the Gly-
Phe(2-Me-Pro)-Gly peptide was not observed, we cannot com-
ment on the role of Phe in this system. In all other cases, com-
parisons are possible, and the Phe does increase the percentage
cis at the adjacent Pro analogue. The substantial upfield chem-
ical shift of the C proton in the cis conformer supports the
existence of the putative interaction between the proline ring
and the aromatic ring of the phenylalanine residue
(supplemental Table 1).
In Table 3, we report G(c-t), the extent to which the pro-
line analogue shows an increased bias for the cis form relative to
proline. To facilitate comparisons, we also convert each EC50
shift into an energy term, G(EC50). We first considered the
homologous series of unsubstituted rings Aze, Pro, and Pip, in
which the ring size expands from 4 to 5 to 6. The percentage cis
and EC50 values track each other; EC50 is Pip  Aze  Pro,
whereas percentage cis is Pip  Aze  Pro (Fig. 6, solid line).
Note that in this simple series, the Phe substituent is critical
because the inherent percentage cis sequence absent the Phe is
Aze Pip Pro (Fig. 6, dotted line). Having an aromatic resi-
due adjacent to the proline alters the cis bias differentially
across this homologous series, and the EC50 values for the
receptor mirror this effect. These data suggest that proline cis-
trans isomerization at this site may play a role in receptor
gating.
Concerning the more dramatic proline mutations, a simple
percentage cis correlation is not evident. It is clear from the
Phe135 mutational studies that receptor function is highly sen-
sitive to side chain polarity at the 135 site (Fig. 5), with increased
side chain hydrophobicity lowering EC50. It seems reasonable
to expect a similar effect at the adjacent Pro136 because Phe and
Pro interact, as shown by themutant cycle analysis. Indeed, our
results suggest a preference for side chain hydrophobicity at the
Pro136 site as well. Mor is structurally very similar to Pip, but it
does not fit into the Aze-Pro-Pip correlation. We propose that
EC50 for Mor is anomalously high because of the increased
polarity relative to Pip. Similarly, flp has a significantly higher
FIGURE 5. Correlation between EC50 and logP for mutations at Phe
135.
Note that the Cha point was not included in the linear fit.
FIGURE6.RelationshipbetweenEC50 values andcis-transpreferences for
Pro and analogues at position 136. All values are relative to Pro. Solid line
and open circles, Pro, Aze, and Pip using cis-trans values determined in the
present study for the Gly-Phe-Xaa-Gly sequence (Table 3). Dashed line and
open diamonds, Pro, Aze, and Pip using cis-trans values previously deter-
mined for sequences that do not have an aromatic N-terminal to the Pro
analogue. Solid squares, data points (flp,Mor, and3-Me-Pro) that deviate from
the trend set by the solid line.
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percentage cis than Pro but only a modest decrease in EC50,
apparently due to the increased polarity of the fluorine substit-
uent. In fact, a second linear correlation can be seen in Fig. 6
involving the Pro-flp-Mor series, although the structural varia-
tion across this series is less consistent than in the Aze-Pro-Pip
trio. 3-Me-Pro shows a smaller percentage cis than Pro but the
lowest EC50 among the amino acids at the 136 sites. Interest-
ingly, adding a single CH3 group to Pro136 has the same effect
on EC50 as adding a single CH3 group to Phe135 (3-Me-Pro and
Me-Phe show the same EC50). Inspection of simple molecular
models leads to an observation that the two CH3 groups could
point into nearly the same region of the receptor when the
proline is in the cis form. Perhaps each CH3 fits into a hydro-
phobic pocket, stabilizing the open state of the receptor and
lowering EC50.
As shown Fig. 6, in the most conservative structural series
(Pro, Pip, and Aze), we do find a trend that is suggestive of
cis-trans isomerization at Pro136. Importantly, this trend is seen
only when the perturbing effect of the Phe residue is included,
justifying the consideration of the Phe-Pro unit as a single
motif. Residues that involve more complex changes do not fit
the correlation, but generally the deviation is consistent with
the notion that increasing side chain hydrophobicity lowers
EC50. From our data, we propose that both cis propensity and
side-chain hydrophobicity at Pro136 simultaneously are deter-
minants of nAChR function. Moreover, the possibility of cis-
trans isomerization at Pro136 being involved in gating cannot be
ruled out.
Summary—The subtle mutations enabled by unnatural
amino acid mutagenesis have allowed a detailed study of the
Phe-Pro motif in the Cys loop of a Cys loop receptor. Mutant
cycle analysis reveals a strong interaction between the two res-
idues and a strong preference for an aromatic residue at posi-
tion 135. In addition, a clear trend is evidentwhereby increasing
hydrophobicity at either Phe135 or Pro136 lowers EC50.
Although the analysis of residue Pro136 is complex, the data
provide evidence supporting a role for the cis conformer in
receptor function.
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